Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $1.8 million.

  • Editas Medicine's Interest & Investment Income fell 4813.03% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 5638.5%. This contributed to the annual value of $14.1 million for FY2024, which is 1994.76% down from last year.
  • Latest data reveals that Editas Medicine reported Interest & Investment Income of $1.8 million as of Q3 2025, which was down 4813.03% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Interest & Investment Income registered a high of $5.1 million during Q3 2023, and its lowest value of $134000.0 during Q1 2021.
  • Over the past 5 years, Editas Medicine's median Interest & Investment Income value was $2.1 million (recorded in 2025), while the average stood at $2.3 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 9140.47% in 2021, then surged by 144971.43% in 2022.
  • Over the past 5 years, Editas Medicine's Interest & Investment Income (Quarter) stood at $175000.0 in 2021, then skyrocketed by 1449.71% to $2.7 million in 2022, then skyrocketed by 88.13% to $5.1 million in 2023, then tumbled by 76.46% to $1.2 million in 2024, then soared by 52.46% to $1.8 million in 2025.
  • Its Interest & Investment Income was $1.8 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.7 million in Q1 2025.